Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2 results

Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Real-World Comparative Effectiveness of Tofacitinib and Tumor Necrosis Factor Inhibitors as Monotherapy and Combination Therapy for Treatment of Rheumatoid Arthritis.
Reed GW, Gerber RA, Shan Y, Takiya L, Dandreo KJ, Gruben D, Kremer J, Wallenstein G. Reed GW, et al. Rheumatol Ther. 2019 Nov 9;6(4):573-86. doi: 10.1007/s40744-019-00177-4. Online ahead of print. Rheumatol Ther. 2019. PMID: 31707603 Free PMC article.
INTRODUCTION: No published studies exist comparing the effectiveness of tofacitinib with other advanced therapies for the treatment of rheumatoid arthritis (RA) in real-world clinical practice. Here, we report differences in …
INTRODUCTION: No published studies exist comparing the effectiveness of tofacitinib with other advanced therapies for t …
Real-World Persistence and Effectiveness of Upadacitinib versus Other Janus Kinase Inhibitors and Tumor Necrosis Factor Inhibitors in Australian Patients with Rheumatoid Arthritis.
Youssef P, Ciciriello S, Tahir T, Leadbetter J, Butcher B, Calao M, Walsh N, O'Sullivan C, Smith T, Littlejohn G. Youssef P, et al. Rheumatol Ther. 2025 Feb;12(1):173-202. doi: 10.1007/s40744-024-00736-4. Epub 2025 Jan 6. Rheumatol Ther. 2025. PMID: 39757285 Free PMC article.
INTRODUCTION: This study sought to describe treatment patterns, persistence, and effectiveness of upadacitinib (UPA) alone and compared to other Janus kinase inhibitors (JAKis) or tumor necrosis factor inhibitors (TNFis) in …
INTRODUCTION: This study sought to describe treatment patterns, persistence, and effectiveness of upadacitinib (UPA) alone and …